Modulo Bio
San Diego
About Modulo Bio
Modulo Bio simulates the neuroimmune system to find medication candidates that target microglia cells. The organization's proprietary neuroimmune platform combines the most recent developments in stem cell biology and neuroscience with software, automation, and artificial intelligence to create novel treatments.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $23.1M
- Funding stage: Seed
- Last round: Seed (Mar 2025)
- Website: modulo.bio
- Phone: +1 6507878325
Industries & Categories
Biopharma, Biotechnology, Medical, Neuroscience, Product Research
Social Profiles
Canonical: https://fsome.com/organization/modulo-bio-98901 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.